COVID-19 |

IRG Summary

The IRG# will consider applications involving translational and clinical investigations that encompass cancer therapeutic development and cancer treatment. Specifically, the IRG# reviews research grant applications related to drug discovery and mechanism of action of cancer therapeutic agents in both in vitro and in vivo model systems; identification and validation of new druggable targets; development and evaluation of experimental therapies of neoplastic diseases; development or optimization of treatment modalities; and radiation biology and therapy.

#charter to be transferred to OCT1, pending approval